Capvizr
THE DEAL, AT A GLANCE

Evvy

From the announcement
01What happenedEvvy raised $40M Series B, announced 2026-09-15From the announcement

Summarized from the deal record's source announcement; not yet independently reviewed.

Read the announcement ↗
02Why it mattersEvvy raised $40M in a Series B to scale an AI-powered precision diagnostics and care platform for women's health, with stated focus on vaginal health and vaginal…From the announcement

Summarized from the deal record's source announcement; not yet independently reviewed.

Read the announcement ↗
Click a part to explore its evidence. Unsupported imagery is withheld rather than guessed.Original record source ↗

Evvy · Financing Record

Explore source-linked visual explanations for Evvy. Unsupported claims are withheld while source review continues.

Record 12341 · Recorded date: 2026-09-15

What it does

Evvy, image from evvy.com

Our at-home vaginal microbiome test is only clinical, validated mNGS vaginal health test — providing you with the most reliable, comprehensive answers from a single swab.

Source: evvy.com ↗

Open record 12341 →

Explore company records →
Free weekday briefing

Know which funding rounds matter before the first call.

Source-linked rounds, lead investors, and the signal behind the capital. One five-minute read.

Free · Unsubscribe anytime